Cargando…
KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancer
KRAS mutations occur in 30–40% of all cases of human colorectal cancer (CRC). However, to date, specific therapeutic agents against KRAS-mutated CRC have not been developed. We previously described the generation of mouse models of colon cancer with and without Kras mutations (CDX2P-G22Cre;Apc(flox/...
Autores principales: | Niitsu, H, Hinoi, T, Kawaguchi, Y, Sentani, K, Yuge, R, Kitadai, Y, Sotomaru, Y, Adachi, T, Saito, Y, Miguchi, M, Kochi, M, Sada, H, Shimomura, M, Oue, N, Yasui, W, Ohdan, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007825/ https://www.ncbi.nlm.nih.gov/pubmed/27526107 http://dx.doi.org/10.1038/oncsis.2016.47 |
Ejemplares similares
-
Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation
por: Miguchi, Masashi, et al.
Publicado: (2016) -
Synbiotics suppress colitis-induced tumorigenesis in a colon-specific cancer mouse model
por: Saito, Yasufumi, et al.
Publicado: (2019) -
Oncogenic mutation in RAS‐RAF axis leads to increased expression of GREB1, resulting in tumor proliferation in colorectal cancer
por: Kochi, Masatoshi, et al.
Publicado: (2020) -
Chlorinated Water Modulates the Development of Colorectal Tumors with Chromosomal Instability and Gut Microbiota in Apc-Deficient Mice
por: Sasada, Tatsunari, et al.
Publicado: (2015) -
Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma
por: Koh, Iemasa, et al.
Publicado: (2016)